vs

Side-by-side financial comparison of CMB.TECH NV (CMBT) and NU SKIN ENTERPRISES, INC. (NUS). Click either name above to swap in a different company.

CMB.TECH NV is the larger business by last-quarter revenue ($592.8M vs $320.6M, roughly 1.8× NU SKIN ENTERPRISES, INC.). CMB.TECH NV runs the higher net margin — 32.3% vs 0.6%, a 31.7% gap on every dollar of revenue. On growth, NU SKIN ENTERPRISES, INC. posted the faster year-over-year revenue change (-12.0% vs -34.6%).

CMB.TECH, before October 2024 known as Euronav, is a crude oil tanker transport company, which consists of VLCCs, Suezmaxes and FSOs.

Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.

CMBT vs NUS — Head-to-Head

Bigger by revenue
CMBT
CMBT
1.8× larger
CMBT
$592.8M
$320.6M
NUS
Growing faster (revenue YoY)
NUS
NUS
+22.5% gap
NUS
-12.0%
-34.6%
CMBT
Higher net margin
CMBT
CMBT
31.7% more per $
CMBT
32.3%
0.6%
NUS

Income Statement — Q4 FY2024 vs Q1 FY2026

Metric
CMBT
CMBT
NUS
NUS
Revenue
$592.8M
$320.6M
Net Profit
$191.2M
$1.8M
Gross Margin
66.9%
Operating Margin
46.4%
34.4%
Net Margin
32.3%
0.6%
Revenue YoY
-34.6%
-12.0%
Net Profit YoY
-63.3%
EPS (diluted)
$1.01
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMBT
CMBT
NUS
NUS
Q1 26
$320.6M
Q4 25
$370.3M
Q3 25
$364.2M
Q2 25
$386.1M
Q1 25
$364.5M
Q4 24
$592.8M
$445.6M
Q3 24
$430.1M
Q2 24
$439.1M
Net Profit
CMBT
CMBT
NUS
NUS
Q1 26
$1.8M
Q4 25
$14.5M
Q3 25
$17.1M
Q2 25
$21.1M
Q1 25
$107.5M
Q4 24
$191.2M
$-36.1M
Q3 24
$8.3M
Q2 24
$-118.3M
Gross Margin
CMBT
CMBT
NUS
NUS
Q1 26
66.9%
Q4 25
70.7%
Q3 25
70.5%
Q2 25
68.8%
Q1 25
67.8%
Q4 24
62.7%
Q3 24
70.1%
Q2 24
70.0%
Operating Margin
CMBT
CMBT
NUS
NUS
Q1 26
34.4%
Q4 25
6.3%
Q3 25
5.9%
Q2 25
8.0%
Q1 25
-2.7%
Q4 24
46.4%
-11.9%
Q3 24
4.2%
Q2 24
-28.6%
Net Margin
CMBT
CMBT
NUS
NUS
Q1 26
0.6%
Q4 25
3.9%
Q3 25
4.7%
Q2 25
5.5%
Q1 25
29.5%
Q4 24
32.3%
-8.1%
Q3 24
1.9%
Q2 24
-26.9%
EPS (diluted)
CMBT
CMBT
NUS
NUS
Q1 26
$0.04
Q4 25
$0.27
Q3 25
$0.34
Q2 25
$0.43
Q1 25
$2.14
Q4 24
$1.01
$-0.73
Q3 24
$0.17
Q2 24
$-2.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMBT
CMBT
NUS
NUS
Cash + ST InvestmentsLiquidity on hand
$38.9M
$198.7M
Total DebtLower is stronger
$2.6B
$223.6M
Stockholders' EquityBook value
$1.2B
$794.1M
Total Assets
$3.9B
$1.4B
Debt / EquityLower = less leverage
2.20×
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMBT
CMBT
NUS
NUS
Q1 26
$198.7M
Q4 25
$239.8M
Q3 25
$253.0M
Q2 25
$265.4M
Q1 25
$213.6M
Q4 24
$38.9M
$198.0M
Q3 24
$237.8M
Q2 24
$232.9M
Total Debt
CMBT
CMBT
NUS
NUS
Q1 26
$223.6M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$2.6B
Q3 24
Q2 24
Stockholders' Equity
CMBT
CMBT
NUS
NUS
Q1 26
$794.1M
Q4 25
$805.2M
Q3 25
$799.8M
Q2 25
$787.8M
Q1 25
$754.0M
Q4 24
$1.2B
$651.5M
Q3 24
$706.9M
Q2 24
$686.2M
Total Assets
CMBT
CMBT
NUS
NUS
Q1 26
$1.4B
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$1.4B
Q1 25
$1.4B
Q4 24
$3.9B
$1.5B
Q3 24
$1.6B
Q2 24
$1.6B
Debt / Equity
CMBT
CMBT
NUS
NUS
Q1 26
0.28×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
2.20×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMBT
CMBT
NUS
NUS
Operating Cash FlowLast quarter
$204.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.07×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMBT
CMBT
NUS
NUS
Q1 26
Q4 25
$16.6M
Q3 25
$27.5M
Q2 25
$35.8M
Q1 25
$389.0K
Q4 24
$204.4M
$25.8M
Q3 24
$31.4M
Q2 24
$51.2M
Free Cash Flow
CMBT
CMBT
NUS
NUS
Q1 26
Q4 25
$5.9M
Q3 25
$17.6M
Q2 25
$35.8M
Q1 25
$-13.2M
Q4 24
$13.2M
Q3 24
$22.8M
Q2 24
$43.1M
FCF Margin
CMBT
CMBT
NUS
NUS
Q1 26
Q4 25
1.6%
Q3 25
4.8%
Q2 25
9.3%
Q1 25
-3.6%
Q4 24
3.0%
Q3 24
5.3%
Q2 24
9.8%
Capex Intensity
CMBT
CMBT
NUS
NUS
Q1 26
Q4 25
2.9%
Q3 25
2.7%
Q2 25
0.0%
Q1 25
3.7%
Q4 24
2.8%
Q3 24
2.0%
Q2 24
1.9%
Cash Conversion
CMBT
CMBT
NUS
NUS
Q1 26
Q4 25
1.15×
Q3 25
1.61×
Q2 25
1.69×
Q1 25
0.00×
Q4 24
1.07×
Q3 24
3.79×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons